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HEALTH FINANCING AND FAMILY PLANNING IN 
THE CONTEXT OF UNIVERSAL HEALTH CARE: 
CONNECTING THE DISCOURSE
INTRODUCTION
Financing is a major challenge and concern for 
the future of family planning (FP) programs. As 
countries commit to increasing access to and 
quality of FP services and to universal health 
care (UHC), it is crucial that UHC schemes 
include FP and other reproductive health (RH) 
services. Strategic purchasing of quality FP 
services from public and private - including for 
profit and not-for-profit - healthcare providers 
could accelerate progress toward UHC.
It is increasingly recognized that the FP2020 
goals will not be met without adequate attention 
to quality; and that a sustained focus on quality 
of care requires financing at the policy and program levels.  While the importance 
of financing is recognized in relation to quality, the ‘how’ of financing FP within the 
context of UHC is not well understood. 
This brief targets the ‘bridge’ constituency that is coalescing between the health 
financing and FP communities of practice around a shared interest in making access 
to health services universal. With this brief, we aim to:
• Document trends in UHC and health financing, drawing out implications for policy
makers and programmers
• Identify opportunities for the FP community of practice to advocate for the inclu-
sion of quality FP services within UHC and health financing discussions
METHODOLOGY AND OUTLINE
This technical brief drew on selected published and grey literature on health financing, 
FP and UHC. The technical brief is divided into four sections:
• Section one outlines salient features of health financing and UHC as well as related
trends
• Section two outlines health financing for FP, current emphasis of financing efforts
and the evidence base
• Section three outlines strategic purchasing and FP and its relationship with quality
FP services
• Section four proposes an organizing framework for strategic purchasing for FP,
outlining purchasing elements and FP considerationsM
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SECTION 1. HEALTH FINANCING AND UHC 
- SALIENT FEATURES
Health systems financing has specific functions and objec-
tives. Financing functions are threefold – revenue gener-
ation, risk pooling and strategic purchasing (WHO, 2010). 
Health financing functions are intended to achieve specific 
objectives – generate sufficient and sustainable financing, 
improve the efficiency and quality of health services, and ex-
pand access to high quality services in a client-centered and 
responsive manner (WHO, 2016). Health financing functions 
and objectives are inter-related; success or failure in one has 
implications for ‘effective coverage’, which is the probability 
that someone who needs an intervention will get it and have 
their health improved as a result (Sparks et al, 2016).
UHC is the articulation of health financing aims, as ex-
pressed in national health strategies. UHC seeks to ensure 
that all citizens should receive the health services that they 
need without financial hardship, in recognition of the intrinsic 
value of health and basic human rights to self-determination, 
dignity, and equality. Progress toward UHC is measured by 
the coverage of key services and financial protection. While 
there is no single authoritative formulation of UHC (Ooms et 
al, 2014), in many countries, UHC includes national health 
insurance (and is often taken as shorthand for this) and 
entitlement schemes, such as free maternal and child health 
services (Maeda et al, 2014). These may be in addition to 
public financing of service provision through budget line-
items and other forms of health service purchasing. 
The drive for UHC has been accompanied by other trends in 
donor assistance, health financing, and health systems or-
ganisation. These trends are not smooth or necessarily linear 
and include the following:
• Increased focus on domestic financing. There is increas-
ing emphasis on domestic financing, particularly as 
countries transition from low- to middle-income country 
(LMIC) status. Despite this emphasis, many sub-Saharan 
African countries spend less than 15% of their govern-
ment budget on health (the Abuja Declaration target), 
and in many cases, these proportions are either stag-
nating or declining over time. Furthermore, as countries 
graduate from low- to middle-income, greater reliance on 
domestic financing does not necessarily translate into in-
creased ‘funding for health’ and may be accompanied by 
widening inequities between the rich and poor (Xu et al, 
2011). Out-of-pocket (OOP) expenditure has continued 
to feature as part of domestic financing and comprises 
over 40% of average total health expenditure in low-in-
come countries (WHO, 2017). Gendered inequities in 
service access and the disproportionate barrier that OOP 
spending creates for women and adolescent girls is rare-
ly recognised or analyzed as part of domestic financing 
(Witter et al, 2017). 
• Stagnation in development assistance for health 
(DAH). Greater reliance on domestic financing has been 
prompted by stagnation of donor funding. Since 2010, 
stagnation has characterized DAH across all health 
focus areas. Past trends and associations suggest that 
this stagnation might be the new reality, rather than just 
a temporary anomaly (Dieleman et al, 2016). There is 
recognition that while DAH remains an important source 
of health financing in many LMIC, it must contribute to 
domestic resource mobilization rather than crowd it out 
(Evans and Pablos-Méndez, 2016). This has prompted 
some donors, such as USAID, to focus on how to respon-
sibly transition financing and support country health 
systems on a trajectory toward full domestic financing 
(USAID, 2018).
• Emphasis on efficiency measures. Given the limitations 
of domestic financing and a context of stagnating DAH, 
there has been greater attention to efficiency in service 
provision. These efforts include allocation of resources 
toward services and inputs that generate better results 
at lower cost, pooling of funds, increasing transparency 
and accountability, strategic purchasing, and strength-
ening managerial capacities at both government and 
facility level (World Bank, 2017). Strategic purchasing is 
viewed as a means of improving quality and efficiency. 
However, poor targeting, inadequate use of evidence, 
and fragmented financing may continue to reduce the 
efficiency of existing investments (Lie et al, 2015). 
• Quality of care. The financing and quality of care agen-
das share the same objective of maximizing the benefit 
derived from available resources and ensuring public 
health impact. However, these agendas may work at 
cross purposes as poor-quality services generate addi-
tional costs, through the underuse, overuse, and misuse 
of interventions and services, while financing arrange-
ments may impede improvements in care (McLoughlin 
and Leatherman, 2003). There is evidence that financ-
ing arrangements strongly influence how institutional 
providers (hospitals and health systems) and individual 
healthcare workers provide health services (McLoughlin 
and Leatherman, 2003). 
• Integrated service delivery and primary health care. 
There have been efforts to move away from vertical, 
single health service focused programs, to integrated 
health services across the life cycle, using primary 
health care (PHC) as the organizing framework. However, 
the content of PHC, both in terms of which interven-
tions are included and which are priorities for universal 
access—has shifted over time (Lawn et al, 2008) and 
may present as competing discourses. For example, the 
economic emphasis of UHC on domestic financing have 
conflated it with insurance, may make it vulnerable to 
political and financial pressure and privilege clinical over 
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2015). Additionally, less powerful groups, such as poor 
women, who have higher health needs and lower financ-
ing capabilities than men, may not be prioritized (Witter 
et al, 2017).  
Health financing and service organisation trends have 
implications for FP. In many LMICs, efforts to increase FP 
financing operate in parallel with the development of UHC 
schemes and essential benefits packages (Mazzili et al, 
2016; Appleford and Camara, 2018). Given this, as countries 
reorganize their health financing functions, there is a risk 
that they insufficiently cover vulnerable populations, such as 
poor women and adolescent girls and boys, or fail to include 
priority services such as FP. This puts FP at risk of being left 
out of benefits packages and related UHC schemes.
SECTION 2. HEALTH FINANCING AND 
FAMILY PLANNING
FP financing comes from a range of sources, including 
international donors, national governments, NGOs and 
clients - the latter, in the form of OOP expenditure. FP has 
enjoyed ‘special attention’ through efforts such as FP2020 
and the World Bank’s Global Financing Facility (GFF), which 
supports governments to address a broad spectrum of 
intervention on the reproductive, maternal, neonatal, child 
and adolescent health (RMNCAH) continuum as part of the 
Global Strategy for Women’s, Children’s and Adolescents’ 
Health.  Other dedicated sources of FP financing are limit-
ed, due to a contraction of DAH in general as well as shifts 
in the political landscape that have created an uncertain 
funding environment for FP (e.g. the Mexico City Policy, and 
shifting donor priorities, notably USAID). Financing through 
client OOP expenditure is also a significant contributor to 
FP financing. It is estimated that OOP comprises nearly half 
(49%) of the costs of reproductive, maternal, neonatal, and 
children’s health (Lie et al, 2015) and will account for most 
of the financing for FP over the next three years (RHSC, 
2018). This form of financing may not be recognised as a 
barrier to access as it may not be viewed as catastrophic or 
a financial hardship for women and girls. As a result, it may 
also not be prioritized by the FP community, given other 
supply- side and demand-side barriers (Lie et al, 2015).
While the FP community of practice recognises the 
importance of sustainable financing, including domestic 
financing, commodities have dominated the discussion 
and policy priorities. This is an important piece of health 
financing for FP, given predicted funding gaps for commod-
ities (RHSC, 2018). It is also the most visible as ‘tracking 
of domestic financing is easiest for commodities since this 
usually entails a budget line item.’ (FP2020, 2018). As a 
result, there are several agencies and technical working 
groups focused on the establishment - and replenishment 
- of budget lines for FP commodities. There has also been
emphasis placed on a Total Market Approach (TMA), to
increase access to priority health products, such as FP
commodities, in a sustainable manner (K4Health, 2018).
This approach seeks to direct subsidies towards those most
in need while allowing the commercial sector to cater for
those willing to pay for FP commodities and services.
Beyond FP commodities, expenditure tracking tends to 
focus on vertical FP financing or is reliant upon efforts to 
disentangle FP service elements from government RH 
accounts. This approach is employed by FP2020, through 
its single financing indicator that tracks progress on annual 
expenditure on FP from government domestic budgets 
(FP2020a, 2018). Tracking is to be aided by national FP 
costed implementation plans (CIPs), ‘multi-year actionable 
roadmaps designed to help governments achieve their 
family planning goals.’ (FP2020a, 2018).  These tend to be 
standalone documents, not integrated into broader health 
planning tools, program requirements, or government bud-
gets. Some of these have been produced at a sub-national 
level given decentralization of health services, which may 
further compound FP expenditure tracking.
The vertical framing of FP financing tends to position FP 
as in competition with other essential health services. This 
often does not win sympathy with health financing counter-
parts and runs counter to health systems objectives, such 
as improved efficiency and service integration. In some 
countries, vertical FP financing is reflective of historical poli-
cies on population programs. In Bangladesh, for example, a 
separate directorate for FP and an independent Division of 
Population Control and FP was established in the Ministry 
of Health and Family Welfare (MoHFW) in 1975 and has 
retained separate financing and structures at national and 
sub-national levels (Bangladesh MoHFW, 2018). While verti-
cal structures may not exist in other contexts, there remains 
some uneasiness with integration, as FP may ‘get lost’ in 
RMNCAH programs or forgotten altogether. For example, 
Marie Stopes International health financing assessments 
from West Africa have highlighted that contraception has 
frequently remained a fee-payable service in private and 
public facilities despite growing exemption schemes for 
maternal and child health (Mazzilli et al, 2016). 
The FP community may also reinforce a siloed approach 
to quality and rights rather than employ a broader UHC 
frame of reference. The rights-based FP agenda and efforts 
to measure this are reflective of this approach. While there 
tends to be emphasis on rights at the point of service 
delivery (e.g. three FP2020 indicators address this), the 
conditions for rights-based FP are better addressed within 
and outside the health sector at political, institutional and 
communal levels, including work to address women’s and 
adolescents’ agency - supported through efforts to address 
gender equality (Ferguson and Desai, 2018). While rights 
are observed in provider-client interactions and can be mea-
sured to a degree, they do not start with these interactions. 
Rights-based FP is implied based on observable conditions 
in which clients seek services, providers operate, or policy 
signals that enable or acknowledge human rights in FP. 
Signal strength, such as commitment to UHC or adequate 
and predictable financing, can have a powerful but indirect 
effect on FP service delivery. Applying a systematic rights 
framework to the design, implementation, and evaluation 
of health financing initiatives, including but not exclusively 
quality measures could strengthen FP services and help to 
move beyond the siloed approach to quality and rights (Cole 
et al, 2018; Boydell et al, 2018).
The lack of ‘common language’ has been recognised 
by the FP community of practice as an obstacle to the 
effective inclusion of FP within health financing and UHC. 
This, at times, has been underpinned by conflicting or 
poorly communicated objectives but may also reflect a lack 
of capacity and tools to facilitate such engagement (Abt 
Associates, 2016). Some organisations have responded by 
increasing the use of market and systems-based analysis 
while others have developed outward facing platforms to 
deepen engagement on this subject (Abt Associates, 2016). 
These have been positioned as building health financing for 
FP ‘literacy’ but may still promote FP-specific language such 
as TMA.  
There have been some recent efforts to analyse FP that 
explore broader financing mechanisms. 
• This has included systematic reviews of specific financ-
ing models (and their effective inclusion of FP), such 
as community financing and community-based health 
insurance (Karra et al, 2016), conditional and uncon-
ditional cash transfers (Khan et al, 2016),  introducing, 
removing, or changing OOP or user fees (Korachais 
et al, 2016), results-based financing (Blacklock et al, 
2016), performance-based incentives (Bellows et al, 
2014), and social protection programs that provide a 
voucher subsidy (Bellows et al, 2016). A summary of 
the systematic reviews concluded that there is ‘limited 
scientific evidence on the effectiveness of the various 
financing mechanisms for contraception’ and that more 
robust studies are required (Lissner and Ali, 2016). 
This was evidenced by the lack of quality and method-
ological rigor in the 17,000 papers identified through 
the systematic reviews, with only 702 selected for full 
text review and only 38 meeting inclusion standards, or 
0.2% of all papers.
• Other studies have focused on the inclusion of FP 
within UHC oriented schemes in ‘transition’ health 
financing contexts. For example, a study conducted by 
Fagen et al (2017) examined FP within social health in-
surance schemes in nine Latin America and Caribbean 
(LAC) countries and found that FP services have been 
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relatively well-integrated into UHC-oriented schemes in 
these contexts; that enrollment in government support-
ed insurance schemes (rather than reliance on free 
provision through public health facilities) was associat-
ed with improved access to and uptake of modern FP 
methods; and, among the poorest quintile of women, 
insured women had a modern contraceptive preva-
lence rate 16.5 percentage points higher than those 
that were uninsured.
• More recently, a seven-country study (Ross et al, 2018) 
concluded that despite the formal inclusion of FP ser-
vices in national benefits packages examined, actual 
integration of these services has faced challenges 
where issues such as unauthorized fees, lack of capaci-
ty, and limited political will, have limited the availability 
of FP services in practice. The study concluded that 
payment mechanisms need to be evaluated to assess 
incentivization of FP services through insurance while 
reliance on public facilities as sole affiliated providers 
for many insurance schemes may limit utilization due 
to low client confidence and the perception of higher 
quality in the private sector. In many of the analyzed 
countries, client confidence in the public sector is low 
and people may prefer to pay for services from private 
providers who offer, or are perceived as offering, high-
er-quality services.
These works and other efforts have attempted to make 
the ‘special case’ for FP within health financing and 
UHC schemes. These considerations include the range of 
commodities and competencies required to deliver high 
quality contraceptive services. These span methods that 
are self-administered to surgical procedures, making FP 
unique amongst primary health and preventative services. 
This range is also reflective of cadres and service levels 
in which FP is delivered, from community-based to higher 
levels of care. The political and stigmatized nature of FP 
and other sexual and reproductive health (SRH) services is 
also unique amongst PHC services. These emanate from 
within the health system as well as the wider socio-ecolo-
gy and may include the FP community itself. For example, 
concerns related to coercion and choice may influence how 
the FP community approaches financing, in the belief that 
this should promote all methods equally and not single out 
any specific method(s) for attention. LARCs for example 
may require differential payment mechanisms, given the 
additional counseling, clinical competency and consum-
ables required for the delivery of these services. A best 
practice guidance advises ‘don’t compensate for delivery of 
specific FP methods with payments that are out of line with 
payments for other services, as this may lead to coercive 
behavior and should be avoided’ (Eichler et al, 2018) sug-
gesting that differential payment may be supported, if this 
is in line with other services. 
SECTION 3. FP AND STRATEGIC 
PURCHASING
FP financing studies, such as those summarized in the 
previous section, reflect the combinations of input and 
output-based financing that exist for FP. Some of these 
are integrated with other PHC services while others may be 
FP specific mechanisms. While these tend to be studied in 
isolation, in practice, they operate concurrently, if not coher-
ently. Sources of FP purchasing may include:
• Contraceptive commodity procurement through a cen-
tralized government body using domestic and/or donor 
financing.  
• Purchasing of healthcare services, including FP, from 
public health facilities through line-item budgets. This 
is often referred to as passive purchasing as national 
governments may allocate budgets based largely on 
funding received the previous year.
• Purchasing of health care services, including FP, from 
public and private health facilities through national 
health insurance on behalf of registered members or 
entitlement schemes, such as free maternity care. 
Often this form of purchasing is referred to as strategic, 
or more active purchasing, as it is based on some form 
of output, such as the number of deliveries attended or 
other health-related outcomes.
• Results-based financing (RBF) often entails financing 
from donors (such as the World Bank and the GFF), 
channeled through the Ministry of Finance to purchase 
services mainly from public health facilities, but may 
also include the private sector. In these schemes, FP is 
generally included as one of several RMNCAH priority 
services. Reimbursements are based on results in the 
form of incentives for reported outputs and quality indi-
cators. RBF relies upon other inputs such as commodi-
ties, staff and infrastructure.
The array of FP financing points serves to illustrate that 
a narrow focus on commodities or line item budgets may 
miss other potential sources of FP purchasing. These may 
be more important over time, particularly if these are posi-
tioned as the main vehicles for UHC, as in the case of na-
tional health insurance in many contexts. Lessons emerging 
from Mexico and Thailand suggest that progress towards 
UHC in terms of developing effective financing mechanisms 
needs to be accompanied by attention to services which 
predominately affect women, such as SRH, and efforts to 
tackle the underlying political and social determinants that 
undermine access for vulnerable and marginalized groups, 
such as poor and marginalised women and adolescents 
(Witter et al, 2017). Where FP and other SRH services 
have been effectively included in national health insurance 
schemes, this has been associated with improved access to 
and uptake of modern FP methods, as demonstrated in the 
LAC region (Fagan et al, 2017). 
Ideally, more ‘active’ strategic purchasing for FP and 
other PHC services, drawing from a range of mechanisms, 
should be implemented and efforts taken to ensure that 
these operate coherently. This is the premise of strategic 
purchasing, defined as the ‘continuous search for the best 
ways to maximise health system performance by deciding 
which interventions should be purchased, how, and from 
whom’ (RESYST, 2014). The ‘how’ or mechanisms through 
which payments for specific services are made can be an 
important determinant of whether and how well services 
are provided (McLoughlin and Leatherman, 2003). In the 
case of FP, research shows that contraceptive discontin-
uation decreases, and contraceptive use increases with 
improved quality of care (Jain et al, 2017; Jain and Winfrey, 
2017). ‘Who’ these payments are made to equally matters. 
In the case of the public sector, payment may not make its 
way to the health facilities delivering the services, further 
constraining whether and how well services are provided. 
The private sector may also be excluded. Considerations 
such as these are critical to FP given that contraceptive 
discontinuation accounted for about 38% of women with 
unmet need and accounted for about 35% of unintended 
pregnancies (Jain et al, 2017; Jain and Winfrey, 2017).
SECTION 4. FP AND FINANCING -  
BRINGING IT ALL TOGETHER
There are well known reasons for investing in FP. FP saves 
money, saves lives and generates broader societal bene-
fits (Singh et al, 2009). While known to the FP community, 
these may not be apparent to health financing audiences. 
Therefore, how FP investment is approached and articu-
lated by the FP community needs to resonate with broader 
UHC and health financing objectives. These are contextu-
ally defined, underpinned by a country’s UHC plans and 
schemes. Not engaging with this wider frame of reference 
reinforces a siloed approach to FP financing that may work 
against FP2020 objectives of increasing domestic financing 
in the long run. It may further position FP as in competition 
to other PHC services and health systems objectives, such 
as service integration. 
How FP is included in UHC and health financing matters. 
Adequate financing has implications for universality and eq-
uity. This is a matter of rights, given the differential health 
risks and needs that women face, including unwanted preg-
nancy. How FP services are compensated under UHC also 
matters and should balance incentives for efficiency with 
incentives for appropriate provision using the rights-based 
approach to user-centered care so that risks of sub-optimal 
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outcomes are mitigated. This suggests that as UHC benefits 
packages are designed, there is need for the FP commu-
nity to advocate for more than simple ‘FP inclusion’; the 
four ‘Ps’ - package, people, provider and payment - matter 
(Mazzilli et al, 2016). Their alignment seeks to reduce OOP 
barriers to FP services, improve quality of services with 
lower discontinuation rates, and reach all women who have 
an unmet need for FP. Common language would facilitate 
greater alignment between FP, health financing and pur-
chasing objectives. An organizing framework for common 
language is proposed in Table 1. This uses a 5P framework 
- package, provider, people, payment and polities - the ratio-
nale and institutional arrangements that frame FP service 
prioritization. 
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